Evidence map›Paper›PMID 28164095›Full record

ArticleAnnals of translational medicine2017

Circulating micro-RNAs as biomarkers of coronary artery disease: is it ready for primetime or still a work in progress?

Surovi Hazarika, Brian H Annex

Open access · hybridAbstract readEditorialComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Annals of translational medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Surovi HazarikaDivision of Cardiovascular Medicine, Robert M. Berne Cardiovascular Research Center, University of Virginia, Charlottesville, USA.
Brian H AnnexDivision of Cardiovascular Medicine, Robert M. Berne Cardiovascular Research Center, University of Virginia, Charlottesville, USA.
University of Virginia · US

Funding

Systems Biology of Angiogenesis in Peripheral Arterial DiseaseR01HL101200 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI POPEL, ALEKSANDER S. · 2010 to 2022
$10.7M
A Bioengineering Approach to Gene Therapy for Peripheral Arterial DiseaseR01HL116455 · NHLBI · UNIVERSITY OF VIRGINIA · PI ANNEX, BRIAN H, FRENCH, BRENT A · 2014 to 2017
$2.7M
MicroRNA 93 in Peripheral Arterial DiseaseR01HL121635 · NHLBI · UNIVERSITY OF VIRGINIA · PI ANNEX, BRIAN H · 2014 to 2017
$1.6M
Role of micro-RNA's in PADK08HL130573 · NHLBI · UNIVERSITY OF VIRGINIA · PI HAZARIKA, SUROVI · 2016 to 2017
$193k
NHLBI NIH HHS K08 HL130573NHLBI NIH HHS R01 HL101200NHLBI NIH HHS R01 HL116455NHLBI NIH HHS R01 HL121635
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID28164095
PMCPMC5253286
OpenAlexW2573007278

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.